Is rare a buy?
Explore the accurate performance information on rare and check if rare is a buy now. Interactive charts show its progress over time, comparing rare against market indices and offering valuable insights.
Keep in mind that past performance does not guarantee future results. Investing requires careful research and professional financial advice.
Price - Ultragenyx Pharmaceutical Inc. (RARE)
Price: $35.61RARE - Summary Performance
-8.65%
Month Performance-15.36%
Year Performance-11.29%
12 Month PerformanceRARE - Month-to-Month Performance Over 12 Months
Check below the chart with the monthly performance of rare in comparison with market indices:
- S&P 500;
- NASDAQ;
- NYSE;
- DOW JONES.
Swipe right for latest column
| ___________ | Jun/24 | Jul/24 | Aug/24 | Sep/24 | Oct/24 | Nov/24 | Dec/24 | Jan/25 | Feb/25 | Mar/25 | Apr/25 | May/25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RARE | 2.39% | 9.54% | 26.12% | -2.17% | -8.21% | -6.59% | -11.67% | 2.28% | -0.26% | -15.63% | 7.65% | -8.65% |
| SP 500 | 2.02% | -0.99% | 5.73% | -2.50% | 2.70% | -1.42% | -5.75% | -0.76% | 6.15% | 4.96% | 2.17% | 1.73% |
| NASDAQ | 2.68% | -0.52% | 6.21% | 0.48% | 1.64% | -3.97% | -8.21% | 0.85% | 9.56% | 6.57% | 3.70% | 2.40% |
| NYSE | 1.16% | -1.42% | 5.37% | -5.80% | 4.72% | 0.15% | -3.16% | -1.45% | 3.50% | 3.26% | 0.14% | 1.75% |
| DOW JONES | 1.85% | -1.34% | 7.54% | -5.27% | 4.70% | -1.58% | -4.20% | -3.17% | 3.94% | 4.32% | 0.08% | 1.77% |
RARE - Cumulative Performance in 12 Months
The chart displays the accumulated performance in 12 months, comparing rare with market indices.This chart shows whether rare has outperformed or lagged the market over the period.